PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab.
Lung cancer (Amsterdam, Netherlands) 2020 Nov .
Wang Haiyong, Shan Qinge, Guo Jun, Han Xiao, Zhao Chenglong, Li Huijuan, Wang Zheh
The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Cancer letters 2008 Feb 259 (2): 177-85.
Kotsinas Athanassios, Evangelou Konstantinos, Sideridou Maria, Kotzamanis George, Constantinides Constantinos, Zavras Athanasios I, Douglass Chester W, Papavassiliou Athanasios G, Gorgoulis Vassilis